Fat'ma Zouhiri

Title: Fat'ma Zouhiri: Innovator in Pharmaceutical Nanotechnology

Introduction

Fat'ma Zouhiri is a notable inventor based in Chatenay-Malabry, France. He has made significant contributions to the field of pharmaceutical nanotechnology, particularly in the development of innovative treatments for hyperlipemia and hypercholesterolemia. His work focuses on the creation of complex molecules that enhance the efficacy of statins.

Latest Patents

Fat'ma Zouhiri holds 1 patent for his invention related to statin nanoparticles. The patent describes a complex made up of at least one molecule of statin or a derivative, covalently bonded to a hydrocarbon radical with at least 18 carbon atoms. This complex can be formed into nanoparticles, which may also exist in the form of a lyophilizate. The invention includes a pharmaceutical composition that utilizes these complexes and nanoparticles for the treatment and prevention of hyperlipemia and hypercholesterolemia.

Career Highlights

Throughout his career, Fat'ma Zouhiri has demonstrated a commitment to advancing pharmaceutical science. His innovative approach to drug formulation has positioned him as a key figure in the field. His research has the potential to improve the quality of life for individuals suffering from lipid disorders.

Collaborations

Fat'ma Zouhiri has collaborated with esteemed colleagues such as Patrick Couvreur and Didier Desmaele. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.

Conclusion

Fat'ma Zouhiri's contributions to pharmaceutical nanotechnology exemplify the impact of innovative thinking in medicine. His work on statin nanoparticles represents a significant advancement in the treatment of lipid-related conditions.